Leukemia
Adult T cell leukemia treated by curcumin
Published in Gene Therapy Weekly, April 13th, 2006
According to a study from Japan, "Activation of the activator protein 1 (AP-1) plays a critical role in oncogenesis by human T-cell leukemia virus type 1 (HTLV-1), the etiologic agent of ATL, and is required for maintenance of the malignant phenotype. Curcumin (diferuloylmethane), the major pigment of the spice turmeric, has anti-tumor activity; however, the effect of curcumin against ATL has not been elucidated."
"In this study, we examined the effects of curcumin on AP-1 activity in HTLV-1-infected T-cell lines," explained M. Tomita and colleagues, University of Ryukyus. "Curcumin suppressed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-04-13)
More Articles from Gene Therapy Weekly
- Liposome Delivery
Cationic liposome decoy complex suppresses tumor necrosis factor alpha - Neuroscience
Basic FGF expression in astrocytes affects dopamine neuron synaptic function and development - Ovarian Cancer
Effective ovarian cancer treatment strategies target Raf-1 mRNA - Prostate Cancer
Prostate cancers are effectively treated using oncolytic herpes simplex virus - RNA Interference
RNA interference allows transgenic screening - Allergy & Immunology
Autoantibodies to diacyl-phosphatidylethanolamine recognize cytoplasmic domains - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
